Novartis Institutes for BioMedical Research, Forum 1, Novartis Campus, CH-4056 Basle, Switzerland.
Biochem Biophys Res Commun. 2010 Oct 1;400(4):543-7. doi: 10.1016/j.bbrc.2010.08.091. Epub 2010 Sep 20.
The MALT1 paracaspase has arginine-directed proteolytic activity. A20 is a dual ubiquitin-editing enzyme involved in termination of NF-κB signaling. Upon T- or B-cell receptor engagement human (h) A20 is cleaved by MALT1 after arginine 439, yielding an N-terminal fragment (hA20p50) and a C-terminal one (hA20p37). The hA20p50 fragment has never been detected directly, thus limiting insight into the functional consequences of MALT1-mediated cleavage of A20. Here, various antibodies were tested, including newly generated hA20p50 and hA20p37 specific antibodies, leading to detection of the hA20p50 fragment produced after MALT1-mediated cleavage of ectopically expressed as well as endogenous A20 proteins. The properties of both A20 fragments, generated upon co-expression with a constitutively active MALT1 protein, were further studied by sub-cellular fractionation and fluorescence microscopy. In contrast to full-length A20 which is particulate and insoluble, we found hA20p50 to be soluble and readily released into the cytosol whereas hA20p37 was partially soluble, thus suggesting loss of compartmentalization as a possible mechanism for MALT1-mediated dampening of A20 function.
MALT1 副半胱氨酸蛋白酶具有精氨酸定向的蛋白水解活性。A20 是一种双泛素编辑酶,参与终止 NF-κB 信号转导。在 T 细胞或 B 细胞受体结合后,人(h)A20 在精氨酸 439 后被 MALT1 切割,生成一个 N 端片段(hA20p50)和一个 C 端片段(hA20p37)。hA20p50 片段从未被直接检测到,因此限制了对 MALT1 介导的 A20 切割的功能后果的深入了解。在这里,测试了各种抗体,包括新生成的 hA20p50 和 hA20p37 特异性抗体,导致检测到在用组成性激活的 MALT1 蛋白异位表达以及内源性 A20 蛋白后产生的 hA20p50 片段。还通过亚细胞分级分离和荧光显微镜进一步研究了与具有组成活性的 MALT1 蛋白共表达产生的两种 A20 片段的特性。与颗粒状和不溶性的全长 A20 相反,我们发现 hA20p50 是可溶性的,容易释放到细胞质中,而 hA20p37 部分可溶性,因此表明区室化的丧失可能是 MALT1 介导的 A20 功能抑制的一种机制。